Geron Company Description

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia.

The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation

Country	United States
Founded	1990
Industry	Biological Products, Except Diagnostic Substances
Employees	229
CEO	Dawn Bir

Contact Details

Address: 919 East Hillsdale Boulevard Foster City, Delaware 94404 United States
Phone	650 473 7700
Website	geron.com

Stock Details

Ticker Symbol	1GERN
Exchange	Borsa Italiana
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
Dawn Bir	Chief Executive Officer
Michelle Robertson	Chief Financial Officer
Andrew Grethlein	Chief Operating Officer
Aron Feingold	Head of Investor Relations